• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » INC Research acquires MEK Consulting

INC Research acquires MEK Consulting

March 6, 2014
CenterWatch Staff

INC Research, a therapeutically focused global CRO, has acquired MEK Consulting, a clinical monitoring-focused CRO based in Lebanon with operations in Greece, Turkey and the Middle East and North Africa (MENA) region. The move supports INC’s strategic business expansion in high-growth regions to deliver global trials, and positions the company as a drug development partner in MENA, which offers access to more than 200 million new patients. 

“The MENA region offers significant opportunities for new drug development due to its large patient populations, highly qualified medical personnel and increasingly sophisticated regulatory environments,” said Jamie Macdonald, INC Research CEO. "The acquisition of MEK Consulting provides INC Research’s customers with access to this expanding region for biopharmaceutical development.”

The acquisition builds on INC Research’s longstanding relationship with MEK Consulting, which spans more than a decade.

Founded in 1999 by Myriam El-Khazen and Selim Dagher, MEK Consulting has more than 40 employees across five countries and experience on more than 120 studies. The company offers an established infrastructure and complementary therapeutic experience, including oncology, general medicine and rare diseases. El-Khazen and Dagher will assume the roles of general manager and executive director, Commercial Operations, respectively, with overall responsibility for managing INC Research’s presence in the region. MEK Consulting will operate as INC Research and will conduct business under the INC Research name.

El-Khazen said, "We believe this acquisition will bring the MENA region and Southern Europe to a new era in clinical research. Being part of INC Research will enable us to bring more trials to the region, benefiting patients and health institutions while providing biopharmaceutical companies access to the capabilities and resources of a global organization.”

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing